157 related articles for article (PubMed ID: 26872805)
1. Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.
Zavadovsky KV; Gulya MO; Lishmanov YB; Lebedev DI
Ann Nucl Med; 2016 Jun; 30(5):325-33. PubMed ID: 26872805
[TBL] [Abstract][Full Text] [Related]
2. The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure.
Lishmanov Y; Minin S; Efimova I; Chernov V; Saushkina Y; Lebedev D; Popov S
Ann Nucl Med; 2013 May; 27(4):378-85. PubMed ID: 23456177
[TBL] [Abstract][Full Text] [Related]
3. Prediction of cardiac events in patients with dilated cardiomyopathy using 123I-BMIPP and 201Tl myocardial scintigraphy.
Inoue A; Fujimoto S; Yamashina S; Yamazaki J
Ann Nucl Med; 2007 Sep; 21(7):399-404. PubMed ID: 17876553
[TBL] [Abstract][Full Text] [Related]
4. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
[TBL] [Abstract][Full Text] [Related]
5. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Okizaki A; Yamamoto W; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
[TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block.
Nowak B; Sinha AM; Schaefer WM; Koch KC; Kaiser HJ; Hanrath P; Buell U; Stellbrink C
J Am Coll Cardiol; 2003 May; 41(9):1523-8. PubMed ID: 12742293
[TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function.
Brandão SC; Nishioka SA; Giorgi MC; Chen J; Abe R; Martinelli Filho M; Hotta VT; Vieira ML; Garcia EV; Meneghetti JC
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):986-96. PubMed ID: 19145431
[TBL] [Abstract][Full Text] [Related]
8. Right atrial size and deformation in patients with dilated cardiomyopathy undergoing cardiac resynchronization therapy.
D'Andrea A; Scarafile R; Riegler L; Salerno G; Gravino R; Cocchia R; Castaldo F; Allocca F; Limongelli G; Di Salvo G; Cuomo S; Pacileo G; Caso P; Russo MG; Calabrò R
Eur J Heart Fail; 2009 Dec; 11(12):1169-77. PubMed ID: 19926601
[TBL] [Abstract][Full Text] [Related]
9. [The impact of cardiac resynchronization therapy on left ventricular diastolic function evaluated by speckle tracking imaging in patients with dilated cardiomyopathy].
Lu J; Dai M; Qian DJ; Zhang CY; Cao LJ; Wang RX
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):940-4. PubMed ID: 24370222
[TBL] [Abstract][Full Text] [Related]
10. Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy.
Ito T; Hoshida S; Nishino M; Aoi T; Egami Y; Takeda T; Kawabata M; Tanouchi J; Yamada Y; Kamada T
Eur J Nucl Med; 2001 Dec; 28(12):1811-6. PubMed ID: 11734920
[TBL] [Abstract][Full Text] [Related]
11. Comparison of perfusion-metabolism mismatch in 99mTc-MIBI and 123I-BMIPP scintigraphy with cardiac magnetic resonance in patients with dilated cardiomyopathy.
Yoshida A; Takano H; Asai K; Yasutake M; Amano Y; Kumita S; Shimizu W; Mizuno K
J Card Fail; 2013 Jul; 19(7):445-53. PubMed ID: 23834920
[TBL] [Abstract][Full Text] [Related]
12. Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study.
D'Andrea A; Caso P; Romano S; Scarafile R; Riegler L; Salerno G; Limongelli G; Di Salvo G; Calabrò P; Del Viscovo L; Romano G; Maiello C; Santangelo L; Severino S; Cuomo S; Cotrufo M; Calabrò R
Eur Heart J; 2007 Nov; 28(22):2738-48. PubMed ID: 17959621
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with nonischaemic dilated cardiomyopathy using gated myocardial perfusion SPECT.
Mukherjee A; Patel CD; Naik N; Sharma G; Roy A
Nucl Med Commun; 2015 May; 36(5):494-501. PubMed ID: 25695610
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of coronary flow reserve for left ventricular functional improvement after cardiac resynchronization therapy in patients with dilated cardiomyopathy.
Djordjevic Dikic A; Nikcevic G; Raspopovic S; Jovanovic V; Tesic M; Beleslin B; Stepanovic J; Giga V; Milasinovic G
Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1344-9. PubMed ID: 25053732
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
[TBL] [Abstract][Full Text] [Related]
16. Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy.
Knuuti J; Sundell J; Naum A; Engblom E; Koistinen J; Ylitalo A; Stolen KQ; Kalliokoski R; Nekolla SG; Bax KE; Airaksinen KE
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1592-8. PubMed ID: 15290120
[TBL] [Abstract][Full Text] [Related]
17. Predicting the response to cardiac resynchronization therapy using 99mTc-tetrofosmin myocardial scintigraphy in patients with drug-refractory heart failure: additional value of the washout of 99mTc-tetrofosmin.
Shigeru M; Fujiwara S; Takamine S; Yoshida A; Kawai H; Shiotani H; Hirata K
Nucl Med Commun; 2014 Sep; 35(9):939-46. PubMed ID: 24977350
[TBL] [Abstract][Full Text] [Related]
18. Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy.
D'Andrea A; Caso P; Scarafile R; Riegler L; Salerno G; Castaldo F; Gravino R; Cocchia R; Del Viscovo L; Limongelli G; Di Salvo G; Ascione L; Iengo R; Cuomo S; Santangelo L; Calabrò R
Eur J Heart Fail; 2009 Jan; 11(1):58-67. PubMed ID: 19147458
[TBL] [Abstract][Full Text] [Related]
19. Myocardial scintigraphy using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to beta-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect.
Yoshinaga K; Tahara M; Torii H; Akimoto M; Kihara K; Tei C
J Cardiol; 2000 May; 35(5):343-51. PubMed ID: 10834178
[TBL] [Abstract][Full Text] [Related]
20. Mechanical Dyssynchrony for Prediction of the Cardiac Resynchronization Therapy Response in Patients with Dilated Cardiomyopathy.
Zavadovskij KV; Saushkin VV; Varlamova YV; Mishkina AI; Shipulin VV; Lebedev DI; Popov SV
Kardiologiia; 2021 Jul; 61(7):14-21. PubMed ID: 34397337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
